Pre-order Enquiry
Request Free Sample
Global Dolutegravir and Its Combination Drug Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID : QYR-18541701 | Publishing Date : 14-Jun-2021 | No. of pages : 110
Detailed TOC of Global Dolutegravir and Its Combination Drug Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
1 Market Overview of Dolutegravir and Its Combination Drug1.1 Dolutegravir and Its Combination Drug Market Overview
1.1.1 Dolutegravir and Its Combination Drug Product Scope
1.1.2 Dolutegravir and Its Combination Drug Market Status and Outlook
1.2 Global Dolutegravir and Its Combination Drug Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Dolutegravir and Its Combination Drug Market Size by Region (2016-2027)
1.4 Global Dolutegravir and Its Combination Drug Historic Market Size by Region (2016-2021)
1.5 Global Dolutegravir and Its Combination Drug Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Dolutegravir and Its Combination Drug Market Size (2016-2027)
1.6.1 North America Dolutegravir and Its Combination Drug Market Size (2016-2027)
1.6.2 Europe Dolutegravir and Its Combination Drug Market Size (2016-2027)
1.6.3 Asia-Pacific Dolutegravir and Its Combination Drug Market Size (2016-2027)
1.6.4 Latin America Dolutegravir and Its Combination Drug Market Size (2016-2027)
1.6.5 Middle East & Africa Dolutegravir and Its Combination Drug Market Size (2016-2027)
2 Dolutegravir and Its Combination Drug Market Overview by Type
2.1 Global Dolutegravir and Its Combination Drug Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Dolutegravir and Its Combination Drug Historic Market Size by Type (2016-2021)
2.3 Global Dolutegravir and Its Combination Drug Forecasted Market Size by Type (2022-2027)
2.4 Dolutegravir
2.5 Abacavir/Dolutegravir/Lamivudine
2.6 Dolutegravir/Rilpivirine
3 Dolutegravir and Its Combination Drug Market Overview by Application
3.1 Global Dolutegravir and Its Combination Drug Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Dolutegravir and Its Combination Drug Historic Market Size by Application (2016-2021)
3.3 Global Dolutegravir and Its Combination Drug Forecasted Market Size by Application (2022-2027)
3.4 Hospital
3.5 Clinic
3.6 Drug Center
3.7 Other
4 Dolutegravir and Its Combination Drug Competition Analysis by Players
4.1 Global Dolutegravir and Its Combination Drug Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dolutegravir and Its Combination Drug as of 2020)
4.3 Date of Key Players Enter into Dolutegravir and Its Combination Drug Market
4.4 Global Top Players Dolutegravir and Its Combination Drug Headquarters and Area Served
4.5 Key Players Dolutegravir and Its Combination Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Dolutegravir and Its Combination Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 ViiV Healthcare (GSK)
5.1.1 ViiV Healthcare (GSK) Profile
5.1.2 ViiV Healthcare (GSK) Main Business
5.1.3 ViiV Healthcare (GSK) Dolutegravir and Its Combination Drug Products, Services and Solutions
5.1.4 ViiV Healthcare (GSK) Dolutegravir and Its Combination Drug Revenue (US$ Million) & (2016-2021)
5.1.5 ViiV Healthcare (GSK) Recent Developments
5.2 Adcock Ingram Limited
5.2.1 Adcock Ingram Limited Profile
5.2.2 Adcock Ingram Limited Main Business
5.2.3 Adcock Ingram Limited Dolutegravir and Its Combination Drug Products, Services and Solutions
5.2.4 Adcock Ingram Limited Dolutegravir and Its Combination Drug Revenue (US$ Million) & (2016-2021)
5.2.5 Adcock Ingram Limited Recent Developments
5.3 Aurobindo Pharma
5.5.1 Aurobindo Pharma Profile
5.3.2 Aurobindo Pharma Main Business
5.3.3 Aurobindo Pharma Dolutegravir and Its Combination Drug Products, Services and Solutions
5.3.4 Aurobindo Pharma Dolutegravir and Its Combination Drug Revenue (US$ Million) & (2016-2021)
5.3.5 Cipla Recent Developments
5.4 Cipla
5.4.1 Cipla Profile
5.4.2 Cipla Main Business
5.4.3 Cipla Dolutegravir and Its Combination Drug Products, Services and Solutions
5.4.4 Cipla Dolutegravir and Its Combination Drug Revenue (US$ Million) & (2016-2021)
5.4.5 Cipla Recent Developments
5.5 Emcure Pharmaceuticals
5.5.1 Emcure Pharmaceuticals Profile
5.5.2 Emcure Pharmaceuticals Main Business
5.5.3 Emcure Pharmaceuticals Dolutegravir and Its Combination Drug Products, Services and Solutions
5.5.4 Emcure Pharmaceuticals Dolutegravir and Its Combination Drug Revenue (US$ Million) & (2016-2021)
5.5.5 Emcure Pharmaceuticals Recent Developments
5.6 LAURUS Labs
5.6.1 LAURUS Labs Profile
5.6.2 LAURUS Labs Main Business
5.6.3 LAURUS Labs Dolutegravir and Its Combination Drug Products, Services and Solutions
5.6.4 LAURUS Labs Dolutegravir and Its Combination Drug Revenue (US$ Million) & (2016-2021)
5.6.5 LAURUS Labs Recent Developments
5.7 Mylan
5.7.1 Mylan Profile
5.7.2 Mylan Main Business
5.7.3 Mylan Dolutegravir and Its Combination Drug Products, Services and Solutions
5.7.4 Mylan Dolutegravir and Its Combination Drug Revenue (US$ Million) & (2016-2021)
5.7.5 Mylan Recent Developments
5.8 Ranbaxy Pharmaceuticals
5.8.1 Ranbaxy Pharmaceuticals Profile
5.8.2 Ranbaxy Pharmaceuticals Main Business
5.8.3 Ranbaxy Pharmaceuticals Dolutegravir and Its Combination Drug Products, Services and Solutions
5.8.4 Ranbaxy Pharmaceuticals Dolutegravir and Its Combination Drug Revenue (US$ Million) & (2016-2021)
5.8.5 Ranbaxy Pharmaceuticals Recent Developments
5.9 Shanghai Desano Pharmaceuticals
5.9.1 Shanghai Desano Pharmaceuticals Profile
5.9.2 Shanghai Desano Pharmaceuticals Main Business
5.9.3 Shanghai Desano Pharmaceuticals Dolutegravir and Its Combination Drug Products, Services and Solutions
5.9.4 Shanghai Desano Pharmaceuticals Dolutegravir and Its Combination Drug Revenue (US$ Million) & (2016-2021)
5.9.5 Shanghai Desano Pharmaceuticals Recent Developments
5.10 JNJ
5.10.1 JNJ Profile
5.10.2 JNJ Main Business
5.10.3 JNJ Dolutegravir and Its Combination Drug Products, Services and Solutions
5.10.4 JNJ Dolutegravir and Its Combination Drug Revenue (US$ Million) & (2016-2021)
5.10.5 JNJ Recent Developments
6 North America
6.1 North America Dolutegravir and Its Combination Drug Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Dolutegravir and Its Combination Drug Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Dolutegravir and Its Combination Drug Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Dolutegravir and Its Combination Drug Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Dolutegravir and Its Combination Drug Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Dolutegravir and Its Combination Drug Market Dynamics
11.1 Dolutegravir and Its Combination Drug Industry Trends
11.2 Dolutegravir and Its Combination Drug Market Drivers
11.3 Dolutegravir and Its Combination Drug Market Challenges
11.4 Dolutegravir and Its Combination Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Figures, Tables and Charts Available in Global Dolutegravir and Its Combination Drug Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
List of TablesTable 1. Global Market Dolutegravir and Its Combination Drug Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027
Table 2. Global Dolutegravir and Its Combination Drug Market Size by Region (2016-2021) & (US$ Million)
Table 3. Global Dolutegravir and Its Combination Drug Market Size Share by Region (2016-2021)
Table 4. Global Dolutegravir and Its Combination Drug Forecasted Market Size by Region (2022-2027) & (US$ Million)
Table 5. Global Dolutegravir and Its Combination Drug Forecasted Market Size Share by Region (2022-2027)
Table 6. Global Dolutegravir and Its Combination Drug Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027
Table 7. Global Dolutegravir and Its Combination Drug Market Size by Type (2016-2021) & (US$ Million)
Table 8. Global Dolutegravir and Its Combination Drug Revenue Market Share by Type (2016-2021)
Table 9. Global Dolutegravir and Its Combination Drug Forecasted Market Size by Type (2022-2027) & (US$ Million)
Table 10. Global Dolutegravir and Its Combination Drug Revenue Market Share by Type (2022-2027)
Table 11. Global Dolutegravir and Its Combination Drug Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027
Table 12. Global Dolutegravir and Its Combination Drug Market Size by Application (2016-2021) & (US$ Million)
Table 13. Global Dolutegravir and Its Combination Drug Revenue Market Share by Application (2016-2021)
Table 14. Global Dolutegravir and Its Combination Drug Forecasted Market Size by Application (2022-2027) & (US$ Million)
Table 15. Global Dolutegravir and Its Combination Drug Revenue Market Share by Application (2022-2027)
Table 16. Global Dolutegravir and Its Combination Drug Revenue (US$ Million) by Players (2016-2021)
Table 17. Global Dolutegravir and Its Combination Drug Revenue Market Share by Players (2016-2021)
Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dolutegravir and Its Combination Drug as of 2020)
Table 19. Date of Key Manufacturers Enter into Dolutegravir and Its Combination Drug Market
Table 20. Global Dolutegravir and Its Combination Drug Top Players Headquarters and Area Served
Table 21. Dolutegravir and Its Combination Drug Product Solution and Service
Table 22. Global Dolutegravir and Its Combination Drug Players Market Concentration Ratio (CR5 and HHI)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. ViiV Healthcare (GSK) Basic Information List
Table 25. ViiV Healthcare (GSK) Description and Business Overview
Table 26. ViiV Healthcare (GSK) Dolutegravir and Its Combination Drug Products, Services and Solutions
Table 27. Revenue (US$ Million) in Dolutegravir and Its Combination Drug Business of ViiV Healthcare (GSK) (2016-2021)
Table 28. ViiV Healthcare (GSK) Recent Developments
Table 29. Adcock Ingram Limited Basic Information List
Table 30. Adcock Ingram Limited Description and Business Overview
Table 31. Adcock Ingram Limited Dolutegravir and Its Combination Drug Products, Services and Solutions
Table 32. Revenue (US$ Million) in Dolutegravir and Its Combination Drug Business of Adcock Ingram Limited (2016-2021)
Table 33. Adcock Ingram Limited Recent Developments
Table 34. Aurobindo Pharma Basic Information List
Table 35. Aurobindo Pharma Description and Business Overview
Table 36. Aurobindo Pharma Dolutegravir and Its Combination Drug Products, Services and Solutions
Table 37. Revenue (US$ Million) in Dolutegravir and Its Combination Drug Business of Aurobindo Pharma (2016-2021)
Table 38. Aurobindo Pharma Recent Developments
Table 39. Cipla Basic Information List
Table 40. Cipla Description and Business Overview
Table 41. Cipla Dolutegravir and Its Combination Drug Products, Services and Solutions
Table 42. Revenue (US$ Million) in Dolutegravir and Its Combination Drug Business of Cipla (2016-2021)
Table 43. Cipla Recent Developments
Table 44. Emcure Pharmaceuticals Basic Information List
Table 45. Emcure Pharmaceuticals Description and Business Overview
Table 46. Emcure Pharmaceuticals Dolutegravir and Its Combination Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in Dolutegravir and Its Combination Drug Business of Emcure Pharmaceuticals (2016-2021)
Table 48. Emcure Pharmaceuticals Recent Developments
Table 49. LAURUS Labs Basic Information List
Table 50. LAURUS Labs Description and Business Overview
Table 51. LAURUS Labs Dolutegravir and Its Combination Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in Dolutegravir and Its Combination Drug Business of LAURUS Labs (2016-2021)
Table 53. LAURUS Labs Recent Developments
Table 54. Mylan Basic Information List
Table 55. Mylan Description and Business Overview
Table 56. Mylan Dolutegravir and Its Combination Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in Dolutegravir and Its Combination Drug Business of Mylan (2016-2021)
Table 58. Mylan Recent Developments
Table 59. Ranbaxy Pharmaceuticals Basic Information List
Table 60. Ranbaxy Pharmaceuticals Description and Business Overview
Table 61. Ranbaxy Pharmaceuticals Dolutegravir and Its Combination Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in Dolutegravir and Its Combination Drug Business of Ranbaxy Pharmaceuticals (2016-2021)
Table 63. Ranbaxy Pharmaceuticals Recent Developments
Table 64. Shanghai Desano Pharmaceuticals Basic Information List
Table 65. Shanghai Desano Pharmaceuticals Description and Business Overview
Table 66. Shanghai Desano Pharmaceuticals Dolutegravir and Its Combination Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in Dolutegravir and Its Combination Drug Business of Shanghai Desano Pharmaceuticals (2016-2021)
Table 68. Shanghai Desano Pharmaceuticals Recent Developments
Table 69. JNJ Basic Information List
Table 70. JNJ Description and Business Overview
Table 71. JNJ Dolutegravir and Its Combination Drug Products, Services and Solutions
Table 72. Revenue (US$ Million) in Dolutegravir and Its Combination Drug Business of JNJ (2016-2021)
Table 73. JNJ Recent Developments
Table 74. North America Dolutegravir and Its Combination Drug Market Size by Country (2016-2021) & (US$ Million)
Table 75. North America Dolutegravir and Its Combination Drug Market Size by Country (2022-2027) & (US$ Million)
Table 76. Europe Dolutegravir and Its Combination Drug Market Size by Country (2016-2021) & (US$ Million)
Table 77. Europe Dolutegravir and Its Combination Drug Market Size by Country (2022-2027) & (US$ Million)
Table 78. Asia-Pacific Dolutegravir and Its Combination Drug Market Size by Region (2016-2021) & (US$ Million)
Table 79. Asia-Pacific Dolutegravir and Its Combination Drug Market Size by Region (2022-2027) & (US$ Million)
Table 80. Asia-Pacific Dolutegravir and Its Combination Drug Market Share by Region (2016-2021)
Table 81. Asia-Pacific Dolutegravir and Its Combination Drug Market Share by Region (2022-2027)
Table 82. Latin America Dolutegravir and Its Combination Drug Market Size by Country (2016-2021) & (US$ Million)
Table 83. Latin America Dolutegravir and Its Combination Drug Market Size by Country (2022-2027) & (US$ Million)
Table 84. Middle East & Africa Dolutegravir and Its Combination Drug Market Size by Players (2016-2021) & (US$ Million)
Table 85. Middle East & Africa Dolutegravir and Its Combination Drug Market Size by Country (2022-2027) & (US$ Million)
Table 86. Dolutegravir and Its Combination Drug Market Trends
Table 87. Dolutegravir and Its Combination Drug Market Drivers
Table 88. Dolutegravir and Its Combination Drug Market Challenges
Table 89. Dolutegravir and Its Combination Drug Market Restraints
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dolutegravir and Its Combination Drug Market Size Year-over-Year 2016-2027 & (US$ Million)
Figure 2. Global Dolutegravir and Its Combination Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 3. Global Dolutegravir and Its Combination Drug Market Share by Regions: 2021 VS 2027
Figure 4. Global Dolutegravir and Its Combination Drug Forecasted Market Size Share by Region (2022-2027)
Figure 5. North America Dolutegravir and Its Combination Drug Market Size (US$ Million) Growth Rate (2016-2027)
Figure 6. Europe Dolutegravir and Its Combination Drug Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 7. Asia-Pacific Dolutegravir and Its Combination Drug Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 8. Latin America Dolutegravir and Its Combination Drug Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 9. Middle East & Africa Dolutegravir and Its Combination Drug Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 10. Global Dolutegravir and Its Combination Drug Market Size Share by Type in 2021 & 2027
Figure 11. Dolutegravir Market Size (US$ Million) YoY Growth (2016-2027)
Figure 12. Abacavir/Dolutegravir/Lamivudine Market Size (US$ Million) YoY Growth (2016-2027)
Figure 13. Dolutegravir/Rilpivirine Market Size (US$ Million) YoY Growth (2016-2027)
Figure 14. Global Dolutegravir and Its Combination Drug Market Size Share by Application in 2021 & 2027
Figure 15. Hospital Market Size (US$ Million) YoY Growth (2016-2027)
Figure 16. Clinic Market Size (US$ Million) YoY Growth (2016-2027)
Figure 17. Drug Center Market Size (US$ Million) YoY Growth (2016-2027)
Figure 18. Other Market Size (US$ Million) YoY Growth (2016-2027)
Figure 19. Dolutegravir and Its Combination Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Top 5 and Top 10 Players Dolutegravir and Its Combination Drug Market Share in 2020
Figure 21. North America Dolutegravir and Its Combination Drug Market Share by Country (2016-2027)
Figure 22. United States Dolutegravir and Its Combination Drug Market Size (2016-2027) & (US$ Million)
Figure 23. Canada Dolutegravir and Its Combination Drug Market Size (2016-2027) & (US$ Million)
Figure 24. Germany Dolutegravir and Its Combination Drug Market Size (2016-2027) & (US$ Million)
Figure 25. France Dolutegravir and Its Combination Drug Market Size (2016-2027) & (US$ Million)
Figure 26. U.K. Dolutegravir and Its Combination Drug Market Size (2016-2027) & (US$ Million)
Figure 27. Italy Dolutegravir and Its Combination Drug Market Size (2016-2027) & (US$ Million)
Figure 28. Russia Dolutegravir and Its Combination Drug Market Size (2016-2027) & (US$ Million)
Figure 29. Nordic Dolutegravir and Its Combination Drug Market Size (2016-2027) & (US$ Million)
Figure 30. Rest of Europe Dolutegravir and Its Combination Drug Market Size (2016-2027) & (US$ Million)
Figure 31. Asia-Pacific Dolutegravir and Its Combination Drug Market Share by Region (2016-2027)
Figure 32. China Dolutegravir and Its Combination Drug Market Size (2016-2027) & (US$ Million)
Figure 33. Japan Dolutegravir and Its Combination Drug Market Size (2016-2027) & (US$ Million)
Figure 34. South Korea Dolutegravir and Its Combination Drug Market Size (2016-2027) & (US$ Million)
Figure 35. Southeast Asia Dolutegravir and Its Combination Drug Market Size (2016-2027) & (US$ Million)
Figure 36. India Dolutegravir and Its Combination Drug Market Size (2016-2027) & (US$ Million)
Figure 37. Australia Dolutegravir and Its Combination Drug Market Size (2016-2027) & (US$ Million)
Figure 38. Rest of Asia-Pacific Dolutegravir and Its Combination Drug Market Size (2016-2027) & (US$ Million)
Figure 39. Latin America Dolutegravir and Its Combination Drug Market Share by Country (2016-2027)
Figure 40. Mexico Dolutegravir and Its Combination Drug Market Size (2016-2027) & (US$ Million)
Figure 41. Brazil Dolutegravir and Its Combination Drug Market Size (2016-2027) & (US$ Million)
Figure 42. Rest of Latin America Dolutegravir and Its Combination Drug Market Size (2016-2027) & (US$ Million)
Figure 43. Middle East & Africa Dolutegravir and Its Combination Drug Market Share by Country (2016-2027)
Figure 44. Turkey Dolutegravir and Its Combination Drug Market Size (2016-2027) & (US$ Million)
Figure 45. Saudi Arabia Dolutegravir and Its Combination Drug Market Size (2016-2027) & (US$ Million)
Figure 46. UAE Dolutegravir and Its Combination Drug Market Size (2016-2027) & (US$ Million)
Figure 47. Rest of Middle East & Africa Dolutegravir and Its Combination Drug Market Size (2016-2027) & (US$ Million)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Keyplayers in Global Dolutegravir and Its Combination Drug Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
ViiV Healthcare (GSK)Adcock Ingram Limited
Aurobindo Pharma
Cipla
Emcure Pharmaceuticals
LAURUS Labs
Mylan
Ranbaxy Pharmaceuticals
Shanghai Desano Pharmaceuticals
JNJ
Request Sample
Request Discount
